GEN Exclusives

More »

GEN Poll

More »
Aug 01, 2013

GSK China Scandal

Chinese officials have detained 22 GlaxoSmithKline (GSK) employees and an unknown number of doctors in the last month, accusing them of misdeeds and bribery. The company is one of about 60 biopharmas currently under investigation by Beijing for pricing policies. (Learn more here.) Do you expect this scandal will have a lasting effect on China’s biopharma industry?

What long-term effect will the GSK scandal have on the biopharma industry in China?

No effect
 
  12.7%
Little effect
 
  40.7%
A big effect
 
  32.0%
Get out now, while you have the chance!
 
  14.7%

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »